111 related articles for article (PubMed ID: 10559598)
21. Protection against pemphigus foliaceus by desmoglein 3 in neonates.
Wu H; Wang ZH; Yan A; Lyle S; Fakharzadeh S; Wahl JK; Wheelock MJ; Ishikawa H; Uitto J; Amagai M; Stanley JR
N Engl J Med; 2000 Jul; 343(1):31-5. PubMed ID: 10882766
[No Abstract] [Full Text] [Related]
22. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice.
Amagai M; Nishikawa T; Nousari HC; Anhalt GJ; Hashimoto T
J Clin Invest; 1998 Aug; 102(4):775-82. PubMed ID: 9710446
[TBL] [Abstract][Full Text] [Related]
23. Pemphigus--decoding the cellular language of cutaneous autoimmunity.
Edelson RL
N Engl J Med; 2000 Jul; 343(1):60-1. PubMed ID: 10882772
[No Abstract] [Full Text] [Related]
24. Immunopathological diagnosis of pemphigus foliaceus.
Jarzabek-Chorzelska M; Jablonska S; Kolacinska-Strasz Z; Sulej I
Dermatology; 2002; 205(4):413-5; author reply 415-6; discussion 416. PubMed ID: 12444343
[No Abstract] [Full Text] [Related]
25. IgA pemphigus--occurrence of anti-desmocollin 1 and anti-desmoglein 1 antibody reactivity in an individual patient.
Kopp T; Sitaru C; Pieczkowski F; Schneeberger A; Födinger D; Zillikens D; Stingl G; Karlhofer FM
J Dtsch Dermatol Ges; 2006 Dec; 4(12):1045-50. PubMed ID: 17176412
[TBL] [Abstract][Full Text] [Related]
26. Detection of pemphigus desmoglein 1 and desmoglein 3 autoantibodies and pemphigoid BP180 autoantibodies in saliva and comparison with serum values.
Andreadis D; Lorenzini G; Drakoulakos D; Belazi M; Mihailidou E; Velkos G; Mourellou-Tsatsou O; Antoniades D
Eur J Oral Sci; 2006 Oct; 114(5):374-80. PubMed ID: 17026501
[TBL] [Abstract][Full Text] [Related]
27. A comparison of anti-desmoglein antibodies and indirect immunofluorescence in the serodiagnosis of pemphigus vulgaris.
Zagorodniuk I; Weltfriend S; Shtruminger L; Sprecher E; Kogan O; Pollack S; Bergman R
Int J Dermatol; 2005 Jul; 44(7):541-4. PubMed ID: 15985020
[TBL] [Abstract][Full Text] [Related]
28. [Immunological tests: Anti desmoglein 1 and 3 antibody].
Amagai M
Nihon Rinsho; 2005 Jul; 63 Suppl 7():571-4. PubMed ID: 16111335
[No Abstract] [Full Text] [Related]
29. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.
Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR
J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453
[TBL] [Abstract][Full Text] [Related]
30. Herpetiform pemphigus with anti-Dsg 1 and full-length BP180 autoantibodies.
Kurashige Y; Mitsuhashi Y; Saito M; Fukuda S; Hashimoto T; Tsuboi R
Eur J Dermatol; 2012; 22(2):269-70. PubMed ID: 22265805
[No Abstract] [Full Text] [Related]
31. Pemphigus vulgaris: the other half of the story.
Kalish RS
J Clin Invest; 2000 Dec; 106(12):1433-5. PubMed ID: 11120748
[No Abstract] [Full Text] [Related]
32. Anti-desmoglein 1 antibodies in Tunisian healthy subjects: arguments for the role of environmental factors in the occurrence of Tunisian pemphigus foliaceus.
Kallel Sellami M; Ben Ayed M; Mouquet H; Drouot L; Zitouni M; Mokni M; Cerruti M; Turki H; Fezza B; Mokhtar I; Ben Osman A; Zahaf A; Kamoun MR; Joly P; Masmoudi H; Makni S; Tron F; Gilbert D
Clin Exp Immunol; 2004 Jul; 137(1):195-200. PubMed ID: 15196262
[TBL] [Abstract][Full Text] [Related]
33. Validation of chemiluminescent enzyme immunoassay in detection of autoantibodies in pemphigus and pemphigoid.
Fujio Y; Kojima K; Hashiguchi M; Wakui M; Murata M; Amagai M; Yamagami J
J Dermatol Sci; 2017 Mar; 85(3):208-215. PubMed ID: 28012821
[TBL] [Abstract][Full Text] [Related]
34. Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay.
Nagasaka T; Fujii Y; Ishida A; Handa M; Tanikawa A; Amagai M; Nishikawa T
Br J Dermatol; 2008 Apr; 158(4):685-90. PubMed ID: 18241273
[TBL] [Abstract][Full Text] [Related]
35. Immunoserological analyses of 55 patients with pemphigus at the Dermatological Department of Kurume University Hospital: an 11-year retrospective study (1996-2006).
Ishii N; Maeyama Y; Karashima T; Nakama T; Kusuhara M; Yasumoto S; Hashimoto T
Int J Dermatol; 2008 Dec; 47(12):1321-2. PubMed ID: 19126032
[No Abstract] [Full Text] [Related]
36. Advances in laboratory evaluation of pemphigus vulgaris.
Gaspari AA
Arch Dermatol; 1999 Nov; 135(11):1418. PubMed ID: 10566852
[No Abstract] [Full Text] [Related]
37. Pemphigus foliaceus with neutrophilic spongiosis evolving to an atypical pemphigus phenotype.
Gabbi TV; Bernardelli IM; Santi CG; Maruta CW; Kodani V; Sotto MN; Li N; Hilario-Vargas J; Diaz LA; Rivitti EA; Aoki V
J Am Acad Dermatol; 2004 Dec; 51(6):1012-3. PubMed ID: 15583603
[TBL] [Abstract][Full Text] [Related]
38. Desmoglein ELISA in the diagnosis of pemphigus and its correlation with the severity of pemphigus vulgaris.
Mortazavi H; Shahdi M; Amirzargar AA; Naraghi ZS; Valikhani M; Daneshpazhooh M; Vasheghani-Farahani A; Sedaghat M; Chams-Davatchi C
Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):53-6. PubMed ID: 19279360
[TBL] [Abstract][Full Text] [Related]
39. Use of domain-swapped molecules for conformational epitope mapping of desmoglein 3 in pemphigus vulgaris.
Futei Y; Amagai M; Sekiguchi M; Nishifuji K; Fujii Y; Nishikawa T
J Invest Dermatol; 2000 Nov; 115(5):829-34. PubMed ID: 11069620
[TBL] [Abstract][Full Text] [Related]
40. Antibodies to desmoglein 1 and 3, and the clinical phenotype of pemphigus vulgaris.
Jamora MJ; Jiao D; Bystryn JC
J Am Acad Dermatol; 2003 Jun; 48(6):976-7. PubMed ID: 12789199
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
